CellSource Co., Ltd.

2026/10/09 19:27 Updated
Market Cap: $39.1M (¥6.2B)
Stock Price: $1.97 (¥311)
Exchange Rate: 1 USD = ¥157.98

Flash Report: Monthly KPI for September, Fiscal Year Ending October 2026

The average daily contracted processing cases in September were 50.2, slightly below the same month last year. Cases for fee-for-service-focused orthopedic clinics decreased, while those for hybrid orthopedic clinics increased. Overall, new partnerships in Group 2 contributed to a rising trend in order volume. The company aims to expand its medium- to long-term order base going forward.

Importance:
Page Updated: October 9, 2026
IR Disclosure Date: October 9, 2026

Key Figures

  • Average contracted processing cases per day: 50.2 cases
  • Fee-for-service-focused orthopedic clinics: 613 cases (9.5% decrease YoY)
  • Hybrid orthopedic clinics: 664 cases (4.6% increase YoY)
  • Order cases: 8,014 cases

AI要約

Key Business Trends

CellSource Co., Ltd. publishes monthly KPI flash reports focused on regenerative medicine-related contracted processing. The average daily contracted cases in September were 50.2, below the same month last year. By department, fee-for-service-focused orthopedic clinics recorded 613 cases, a 9.5% decrease YoY, while hybrid orthopedic clinics recorded 664 cases, a 4.6% increase YoY. Promotion measures supported by new partnerships in Group 2 have contributed, and total order cases expanded to 8,014 compared with the same period last year.

Future Initiatives and Market Outlook

Through KPI revisions that clarify the role-sharing between Group 1 and Group 2, the company plans to support the launch of newly partnered clinics and promote utilization to expand the order base. Although raising fee-for-service volumes may be challenging in some situations, the company aims for stable growth in contracted cases overall by expanding hybrid models.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

CellSource Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →